Adipose cells for chondrocyte applications
AssigneeSpinalCyte, LLC
InventorPete O'Heeron
Life of this patent
Estimating the term…
Abstract
The present disclosure concerns methods and compositions for differentiating cells, including adipose cells, into chondrocyte-like cells via in vitro, ex vivo, and/or in vivo mechanical strain. In particular aspects, adipose cells or re-differentiated adipose cells that are chondrocyte-like cells, are delivered to a joint or are shaped into cartilage. In some embodiments, the adipose cells may be delivered to a joint, such as an intervertebral disc, following which the cells differentiate into chondrocyte-like cells to treat dysfunction of cartilage therein, including to repair degenerated discs, for example. In certain aspects, the cells prior to delivery to the individual are managed in the absence of growth factors, in vitro mechanical strain, and/or matrix molecules, for example.
Claims50
A method of inducing de-differentiation of adipose cells to chondrocyte-like cells, comprising the steps of:
- obtaining differentiated adipose cells from an individual;
- and
- inducing de-differentiation of the differentiated adipose cells to chondrocyte-like cells by subjecting the adipose cells to mechanical strain.
A method of inducing de-differentiation of adipose cells to chondrocyte-like cells, comprising the steps of
- obtaining differentiated adipose cells from an individual;
- and
- inducing de-differentiation of the differentiated adipose cells to chondrocyte-like cells by subjecting the adipose cells to mechanical strain, wherein the mechanical strain comprises low oxygen tension, intermittent hydrostatic pressure, fluid shear stress, or a combination thereof.
Dependencies are inferred from the claim text.